Arthritis Res Ther Volume 7 Issue 1 |
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
ReviewToll-like receptor downstream signalingTaro Kawai1 and Shizuo Akira1,2  1ERATO, Japan Science and Technology Agency, Osaka, Japan 2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan author email corresponding author email
Arthritis Res Ther 2005,
7:12-19doi:10.1186/ar1469
|
|
| Published: |
30 November 2004 |
Abstract
The family of Toll-like receptors (TLRs) senses conserved structures found in a broad range of pathogens, causing innate immune responses that include the production of inflammatory cytokines, chemokines and interferons. The signal transduction is initiated from the Toll/interleukin-1 receptor (TIR) domain of TLRs after pathogen recognition. Almost all TLRs use a TIR-containing adapter MyD88 to activate a common signaling pathway that results in the activation of NF-κB to express cytokine genes relevant to inflammation. Recently, three further TIR-containing adapters have been identified and shown to selectively interact with several TLRs. In particular, activation of the TRIF-dependent pathway confers antiviral responses by inducing anti-viral genes including that encoding interferon-β. Taken together, these results indicate that the interaction between individual TLRs and the different combinations of adapters directs appropriate responses against distinct pathogens. |